Sex differences in Alzheimer’s disease: a systematic review of two decades of neuroimaging research
Open Access
- 16 January 2026
- journal article
- review article
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 99 (1180) , 702-713
Abstract
Objectives: Given the heterogeneous nature of Alzheimer’s disease (AD) and its higher prevalence in females, it is crucial to understand sex-related differences in AD presentation and changes in the brain. Methods: This systematic review investigates sex differences in AD and summarizes key findings from neuroimaging studies over the past two decades to examine how genetics, hormones, and lifestyle factors influence neuroimaging biomarkers and their correlation with cognitive decline and AD progression. A comprehensive literature search was conducted across several databases for human studies from 2004 to 2024 related to AD, biological sex differences, and neuroimaging. Results: After a 3-step review process, the final extraction included 120 peer-reviewed studies using various neuroimaging modalities, such as MRI, amyloid-beta PET, tau-PET, and fluorodeoxyglucose (FDG) PET, to investigate sex as a biological predictor variable in adults with or at risk for AD. Over 90% of the reviewed studies identified clear sex-specific patterns of imaging biomarkers related to cognitive reserve, hormonal changes, APOE-ɛ4 genotype, inflammation, vascular health, and lifestyle factors. Machine learning studies increasingly incorporate sex as a key variable, revealing sex-specific biomarkers and improving model performance in predicting disease status and progression. Conclusions: Considering biological sex in AD research is essential for improving diagnostic accuracy, tailoring interventions, and health outcomes. Advances in knowledge: This systematic review identifies sex-specific patterns in neuroimaging biomarkers of AD, influenced by cognitive reserve, hormones, APOE-ɛ4 genotype, inflammation, vascular health, and lifestyle. Recognizing these differences is crucial for understanding, diagnosis, and treatment efficacy.Keywords
Funding Information
- National Institutes of Health
- National Institute on Aging (P30 AG066444)
- National Institute on Aging (P01 AG003991)
- National Institute on Aging (P01 AG026276)
- National Institute on Aging (R01 AG052550)
- National Institute on Aging (R01 AG054567)
- National Institute on Aging (U19 AG032438)
- National Institute on Aging (UF1 AG032438)
- National Institute on Aging (R01AG074909)
- National Institute on Aging (K01AG080123)
- National Center for Advancing Translational Sciences (UL1TR002345)
This publication has 73 references indexed in Scilit:
- Serum Bile Acids Improve Prediction of Alzheimer's Progression in a Sex‐Dependent MannerAdvanced Science, 2023
- Algorithmic Fairness of Machine Learning Models for Alzheimer Disease ProgressionJAMA Network Open, 2023
- Assessment of Demographic, Genetic, and Imaging Variables Associated With Brain Resilience and Cognitive Resilience to Pathological Tau in Patients With Alzheimer DiseaseJAMA Neurology, 2020
- Association of Intracranial Atherosclerotic Disease With Brain β-Amyloid DepositionJAMA Neurology, 2020
- Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of InterventionsCochrane Database of Systematic Reviews, 2019
- Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer DiseaseJAMA Neurology, 2017
- Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid DepositionJAMA, 2017
- Prevalence of Cerebral Amyloid Pathology in Persons Without DementiaJAMA, 2015
- Age, Sex, andAPOEε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life SpanJAMA Neurology, 2015
- Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer DiseaseJAMA, 1997